Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 19.015\% hERG inhibition at a concentration of 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
(a) CCCCCCOc1ccc(C(=O)O)cc1C#N
(b) COc1ccc(C(=O)Nc2ccccc2C(=O)NC(C(=O)NCc2ccco2)C(C)C)cc1
(c) CCCn1c2ccc(C)cc2c2nnc(SCCN3CCOCC3)nc21
Answer: c. CCCn1c2ccc(C)cc2c2nnc(SCCN3CCOCC3)nc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCn1c2ccc(C)cc2c2nnc(SCCN3CCOCC3)nc21
CCCn1c2ccc(C)cc2c2nnc(SCCN3CCOCC3)nc21
4-[2-[(8-methyl-5-propyl-[1,2,4]triazino[5,6-b]indol-3-yl)sulfanyl]ethyl]morpholine